Compare MPLX & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MPLX | IDXX |
|---|---|---|
| Founded | 2012 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 55.0B | 57.1B |
| IPO Year | 2012 | 1991 |
| Metric | MPLX | IDXX |
|---|---|---|
| Price | $56.21 | $678.36 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 10 |
| Target Price | $58.83 | ★ $700.50 |
| AVG Volume (30 Days) | ★ 1.5M | 445.6K |
| Earning Date | 02-03-2026 | 02-02-2026 |
| Dividend Yield | ★ 7.72% | N/A |
| EPS Growth | 11.31 | ★ 21.65 |
| EPS | 4.72 | ★ 12.60 |
| Revenue | ★ $11,632,000,000.00 | $4,167,411,000.00 |
| Revenue This Year | $18.07 | $12.15 |
| Revenue Next Year | $4.09 | $8.72 |
| P/E Ratio | ★ $11.82 | $54.58 |
| Revenue Growth | 5.53 | ★ 8.39 |
| 52 Week Low | $44.60 | $356.14 |
| 52 Week High | $57.16 | $769.98 |
| Indicator | MPLX | IDXX |
|---|---|---|
| Relative Strength Index (RSI) | 61.99 | 40.21 |
| Support Level | $54.36 | $687.46 |
| Resistance Level | $56.10 | $705.82 |
| Average True Range (ATR) | 1.01 | 14.98 |
| MACD | 0.11 | -2.49 |
| Stochastic Oscillator | 79.48 | 12.27 |
MPLX is a partnership that owns pipelines and gathering and processing assets with extensive holdings in the Appalachian and Permian regions. The asset base is made up of crude oil and refined products assets dropped down from Marathon Petroleum, its sponsor, and natural gas and natural gas liquids gathering and processing assets that were purchased or built.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.